At the age of 27, a woman underwent a preventive double mastectomy and immediate breast reconstruction after discovering she carried a faulty BRCA1 gene, significantly increasing her risk of developing breast and ovarian cancer. The procedure, conducted in February 2019 at the Royal Free Hospital in north London, was part of her proactive approach to reduce her cancer risk.
Her decision followed a family history marked by breast cancer: her paternal grandmother died from the disease in her 40s, and her father tested positive as a carrier of the BRCA1 mutation in 2013, prompting her own genetic testing in 2015. Genetic counseling revealed she had an approximately 80 percent increased likelihood of developing breast cancer, a risk she chose to mitigate through surgery.
Despite being young and aware of limitations such as losing the ability to breastfeed, she settled on having the mastectomy at 27, a timeline influenced in part by the experience of journalist Lisa Lynch, who was diagnosed with breast cancer at 28. Throughout the decision-making process, she worked closely with breast surgeon Mrs Fawzia Imtiaz Crosbie and plastic surgeon Dr Dan Marsh. While initially interested in DIEP flap reconstruction, which uses abdominal tissue, she ultimately opted for implant-based reconstruction due to her body composition.
The surgical approach included preserving her nipples to maintain a natural appearance, although this carries a low risk—estimated under 5 percent—of cancer recurrence in the remaining tissue. This method parallels the approach taken by actress Angelina Jolie, who publicly shared her own preventive mastectomy and reconstruction after testing positive for the same gene mutation.
Recovery was physically challenging. After discharge from the hospital, she experienced intense pain and had limited access to strong pain medication, requiring her breast surgeon to personally deliver co-codamol. She depended heavily on family support during the initial weeks, citing difficulties with mobility and self-care. Over time, swelling decreased, and scarring became minimal, contributing to her overall satisfaction with the surgical outcome.
Her reconstructed breasts appear natural, a result she attributes to the surgical technique chosen by Mrs Crosbie, who recommended scars positioned to be less visible when wearing bikinis. While the surgery eliminated her breast cancer risk, she faces other implications, notably the inability to breastfeed, which has been an emotional challenge as she observes friends sharing that experience.
The BRCA mutation is notably more prevalent in the Ashkenazi Jewish population, among which about one in 40 individuals carries the gene, compared to lower rates among Sephardi Jews and the general UK population. In response, the NHS launched a free genetic testing program targeting adults with at least one Jewish grandparent. This initiative saw over 44,000 participants and identified more than 700 carriers.
Since her surgery, she has become an advocate for breast cancer awareness, volunteering with the charity CoppaFeel! to encourage regular self-examination and early detection. She acknowledges that results of mastectomies and reconstructions can vary widely but expresses confidence and positivity about her body and the life-saving decision she made.